We are live on
!
Find out more
Lord, Abbett & Co Portfolio holdings
AUM
$34.9B
1-Year Est. Return
72.7%
This Fund
S&P 500
This Quarter
Est. Return
+32%
1 Year Est. Return
+72.7%
3 Year Est. Return
+273.6%
5 Year Est. Return
+458.95%
10 Year Est. Return
+2,980.6%
AUM
$34.9B
AUM Growth
+$4.31B
(+14%)
Cap. Flow
-$2.22B
Cap. Flow
% of AUM
-6.35%
Top 10 Holdings %
Top 10 Hldgs %
20.67%
Holding
642
New
79
Increased
166
Reduced
202
Closed
83
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$250M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$230M |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$195M |
| 4 |
Datadog
DDOG
|
+$133M |
| 5 |
MAIR
Madison Air Solutions
MAIR
|
+$124M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Northrop Grumman
NOC
|
+$191M |
| 2 |
Amazon
AMZN
|
+$167M |
| 3 |
TERN
Terns Pharmaceuticals
TERN
|
+$148M |
| 4 |
Gilead Sciences
GILD
|
+$141M |
| 5 |
Allegion
ALLE
|
+$139M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.4% |
| 2 | Industrials | 18.28% |
| 3 | Healthcare | 12.58% |
| 4 | Financials | 11.4% |
| 5 | Consumer Discretionary | 5.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Unusual Machines
UMAC
$1.3B
| $5.73M | 0.02% |
+257,127
| New | +$4.76M |
|
|
SEZL
402
Sezzle
SEZL
$3.99B
| $5.72M | 0.02% |
+33,343
| New | +$3.51M |
|
403
Mayville Engineering Co
MEC
$506M
| $5.7M | 0.02% |
+152,175
| New | +$4.07M |
|
404
Warby Parker
WRBY
$3.06B
| $5.68M | 0.02% |
187,340
-1,898
| -1% | -$47K |
|
405
Northern Oil and Gas
NOG
$2.74B
| $5.53M | 0.02% |
304,491
-1,690
| -0.6% | -$40.1K |
|
406
Worthington Enterprises
WOR
$3.05B
| $5.46M | 0.02% |
101,568
-14,861
| -13% | -$828K |
|
407
UBS Group
UBS
$169B
| $5.37M | 0.02% |
+108,318
| New | +$4.93M |
|
408
Addus HomeCare
ADUS
$2.23B
| $5.31M | 0.02% |
52,851
-252
| -0.5% | -$23.8K |
|
409
H.B. Fuller
FUL
$2.85B
| $5.25M | 0.02% |
90,064
-429
| -0.5% | -$26.4K |
|
410
Rocket Lab Corp
RKLB
$42.1B
| $5.24M | 0.02% |
51,578
-194,074
| -79% | -$19.3M |
|
411
Take-Two Interactive
TTWO
$39.9B
| $5.13M | 0.01% |
20,541
-12,118
| -37% | -$2.67M |
|
412
TFI International
TFII
$11B
| $5.11M | 0.01% |
+35,500
| New | +$5.01M |
|
413
Deckers Outdoor
DECK
$11.2B
| $5.08M | 0.01% |
51,185
+217
| +0.4% | +$22.9K |
|
|
JBIO
414
Jade Biosciences
JBIO
$1.24B
| $5.04M | 0.01% |
+226,606
| New | +$4.73M |
|
415
Gilat Satellite Networks
GILT
$766M
| $5M | 0.01% |
375,697
-19,961
| -5% | -$327K |
|
416
Arcos Dorados Holdings
ARCO
$1.72B
| $4.88M | 0.01% |
605,707
-1,194,293
| -66% | -$10.3M |
|
417
Hudbay
HBM
$12.9B
| $4.84M | 0.01% |
+205,000
| New | +$5.18M |
|
|
ALMR
418
Alamar Biosciences
ALMR
$2.08B
| $4.81M | 0.01% |
+177,552
| New | +$4.02M |
|
419
Scotiabank
BNS
$113B
| $4.78M | 0.01% |
+54,998
| New | +$4.33M |
|
420
Vishay Precision Group
VPG
$862M
| $4.77M | 0.01% |
31,813
-104,927
| -77% | -$9.74M |
|
421
Ulta Beauty
ULTA
$23.5B
| $4.69M | 0.01% |
10,390
-3,708
| -26% | -$1.88M |
|
|
FBRX
422
DELISTED
Forte Biosciences
FBRX
| $4.47M | 0.01% |
210,442
+95,807
| +84% | +$2.27M |
|
423
Idexx Laboratories
IDXX
$41B
| $4.4M | 0.01% |
8,363
-79,884
| -91% | -$44.8M |
|
424
uniQure
QURE
$3.17B
| $4.39M | 0.01% |
+95,322
| New | +$2.5M |
|
425
American Public Education
APEI
$830M
| $4.36M | 0.01% |
81,193
+16,507
| +26% | +$907K |
|
Similar funds
DCP
MIC
RIM
Lord, Abbett & Co's Q2 2026 Portfolio in Review
As of Q2 2026, Lord, Abbett & Co held 642 positions worth $34.9B, up 14% from $30.6B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Lord, Abbett & Co withdrew a net $2.22B in Q2 2026, closing 83 positions and reducing 202 holdings. Its most notable exit was Northrop Grumman, an estimated $191M position sold in full.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 24% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Lord, Abbett & Co opened a new position in Bank of New York Mellon worth $206M.
- Lord, Abbett & Co's largest Q2 2026 buy was Bank of New York Mellon: 1,423,465 shares worth $206M.
- Lord, Abbett & Co added most to UnitedHealth in Q2 2026, an estimated $250M increase.
- Lord, Abbett & Co's biggest Q2 2026 reduction was Amazon, cutting an estimated $167M.
- Lord, Abbett & Co fully exited Northrop Grumman in Q2 2026, selling an estimated $191M.
- Lord, Abbett & Co's ten largest holdings make up 21% of its $34.9B portfolio in Q2 2026.
- Lord, Abbett & Co opened 79 new positions and closed 83 in Q2 2026.
- Lord, Abbett & Co's portfolio value rose 14% quarter-over-quarter to $34.9B.
Based on Lord, Abbett & Co's 13F filing for Q2 2026, filed 14 Aug 2026.